Having dense breasts increases a person’s risk of developing breast cancer, and it can also make it more challenging for ...

Further, Hologic controls roughly 80% of the US digital 3D mammography market through share gains over the past dozen years. While 3D adoption has slowed, Hologic's clinical data still gives it an ...

Further demonstrating its leadership in breast imaging AI, Hologic is also introducing its next-generation Genius AI Detection PRO solution for use in the United States. This advanced cancer ...

For the first time, RSNA attendees will experience Hologic’s Envision Mammography Platform, which offers patients a high-speed Hologic 3D mammogram with an industry-leading 2.5-second scan time.

Hologic HOLX is currently trading at a forward price-to-earnings (P/E) multiple of 17.62X, well below the industry average of 32.42X. The company, specializing in medical devices for women’s health, ...

December 02, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq ... Friedewald, MD, Vice Chair for Women’s Imaging, Department of Radiology, Northwestern Feinberg School of Medicine.

Shares of Hologic, Inc. (NASDAQ:HOLX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the firm, Marketbeat ...

Hologic’s FDA-approved Genius Digital Diagnostic System or Digital Pap test combines AI and advanced digital imaging to provide customers more sensitive disease detection and a streamlined ...

SmartMammo Dx, the AI algorithm within SmartMammo 1, is now FDA-cleared to be compatible with GE HealthCare’s Senographe Pristina™ mammography systems. SmartMammo Dx was first cleared in May 2012 in ...